試す - 無料

Innovation serves as the backbone for Agilent: Celebrating 25 years in India

Bio Spectrum

|

BioSpectrum India Jan 2025

2024 marks Agilent's 25th anniversary in India. To celebrate this momentous occasion, Agilent announced the launch of two new products for the Indian market- Infinity III LC Series and New ProteoAnalyzer System, at the 17th edition of CPHI & PMEC India, organised by Informa Markets, from 26 to 28 November at the India Expo Centre, Greater Noida, Delhi-NCR.

Innovation serves as the backbone for Agilent: Celebrating 25 years in India

Bharat Bhardwaj, Vice President and General Manager – APAC and Samir Vyas, Associate Vice President, Sales – APAC, shared more details about these new products at the event.

What are the unique features of the new products (Agilent Infinity III LC Series and New ProteoAnalyzer System) being launched in India?

Bharat Bhardwaj: This is not just for the Indian or Asian market, this is a global launch. At CPHI, we had a live product display where our customers could observe, and see the functionality of it, ask questions and get themselves comfortable with the new product. There are loads of features which come along with the products, but there are a lot of inputs from the customers which are embedded as we have built the products, whether it is in the form of efficiency, or in the form of productivities, with sustainability or even automation and connectivity.

With the introduction of the new LC systems, Agilent is revolutionising the LC user experience.

These systems significantly enhance task automation, connectivity, predictive feedback, and error reduction. The innovative built-in sample tracking, utilising barcoding and camera technologies ensures the elimination of sample mix-ups, providing users with greater accuracy and peace of mind.

On the other hand, the Agilent ProteoAnalyzer System brings added efficiency, versatility, and reliability, particularly in protein QC workflows. Automating the separation, data processing, and simplifying sample preparation steps streamlines the analysis workflow, which improves efficiency and reduces training and related labour costs. The system also can analyse a wide range of sample types, from crude lysates to purified fractions. It can analyse different sizes and types of proteins in a single run and consistently deliver accurate results, reducing the need for time-consuming and costly reanalysis.

Bio Spectrum からのその他のストーリー

Bio Spectrum

New England Biolabs launches NEBNext low-bias small RNA library prep kit

US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels

Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr

Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Al/loT-Driven Real-time Cardiac Event Prediction & Treatment

It is anticipated that between 2025 and 2050, a significant 50.2 per cent increase in cardiovascular mortality rates will result in 35.6 million cardiovascular deaths by 2050, of which ischemic heart disease or coronary heart disease will remain the leading cause, accounting for 56.2 per cent of fatalities in 2050.

time to read

2 mins

September 2025

Bio Spectrum

SCHOTT announces launch of syringe and cartridge glass tubing in India

SCHOTT, a global pioneer in specialty glass, has announced the addition of syringe and cartridge glass tubing to its existing state-ofthe-art manufacturing capabilities in Jambusar, Gujarat.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

ICMR expands collaborative partnership with CEPI for vaccine research

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Indian Council of Medical Research (ICMR) have expanded their collaborative partnership through a newly signed Memorandum of Understanding (MOU).

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

AMTZ to open India's first advanced 3D printing hub for orthopaedic implants

In a landmark collaboration that spans three continents, OIC International (USA), Medi Mold, part of the Andhra Pradesh Medtech Zone (AMTZ) (India), and AddUp, a subsidiary of Fives Group (France) have announced a strategic partnership to establish India's most advanced orthopaedic implant manufacturing facility powered by 3D printing and precision engineering.

time to read

1 min

September 2025

Bio Spectrum

Alveolus Bio secures strategic investment from Shilpa Medicare

Alveolus Bio, a US-based respiratory drug development biotech company founded by Dr Vivek Lal from University of Alabama at Birmingham, has announced a strategic financing round led by Raichur-based Shilpa Medicare, a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.

time to read

1 min

September 2025

Bio Spectrum

JNCASR explores potential cure for Alzheimer's Disease

Researchers from Bengaluru-based Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute of the Department of Science and Technology (DST) have explored altered miRNAs in the Alzheimer's Disease (AD) brain and also probed the potential of miRNAs to be biomarkers for early, specific and accurate clinical diagnosis of AD.

time to read

1 min

September 2025

Bio Spectrum

Aster DM Healthcare to inject Rs 580 Cr to build 5th hospital in Bengaluru

Aster DM Healthcare, one of India's leading integrated healthcare providers, in a move to strengthen its footprint in one of India's fastest-growing healthcare hubs, Bengaluru, has announced Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.

time to read

1 min

September 2025

Listen

Translate

Share

-
+

Change font size